| Bioactivity | P2Y12 antagonist 1 (compound 26) is a P2Y12 receptor antagonist with a Ki of 3.13 μM. P2Y12 antagonist 1 can be used to inhibit platelet aggregation and is a potential antithrombotic agent[1]. |
| Target | Ki: 3.13 μM (P2Y12 Receptor) |
| CAS | 6222-65-7 |
| Formula | C20H15N3O5S |
| Molar Mass | 409.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bromaminic acid derivatives as P2Y12 receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases. World Intellectual Property Organization, WO2008107211 A2 2008-09-12. |
P2Y12 antagonist 1
CAS: 6222-65-7 F: C20H15N3O5S W: 409.42
P2Y12 antagonist 1 (compound 26) is a P2Y12 receptor antagonist with a Ki of 3.13 μM. P2Y12 antagonist 1 can be used to
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.